20/02/2019 - 09:34

Key cancer drug trial underway for PharmAust

20/02/2019 - 09:34


Upgrade your subscription to use this feature.

PharmAust has kicked-off its highly-anticipated Phase I clinical trials for its flagship anti-cancer drug Monepantel in dogs using the first batch of 2000 tablets manufactured to its new and better-tasting formulation. The initial component of the trial is designed to validate the performance of the drug in different dietary settings that dogs may encounter at home. First results are expected in the middle of March this year.

Subscribe today for award-winning, unbiased and trusted journalism

Subscription Options